Paratek Announces First Milestone Towards Creating A U.S. Manufacturing Supply Chain For NUZYRA Under BARDA Project BioShield Contract
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) today announces the commercial availability of U.S.-produced NUZYRA® (omadacycline) tablets. This milestone follows a successful technology transfer by Paratek and
